PMID: 9194107Jun 1, 1997Paper

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

The Pediatric Infectious Disease Journal
D A RichardU B Schaad

Abstract

More data on the efficacy and safety of ciprofloxacin in pediatric cystic fibrosis patients are needed. One hundred eight pediatric cystic fibrosis patients (ages 5 to 17 years) with acute bronchopulmonary exacerbations entered a randomized multicenter trial designed to compare the safety and efficacy of antipseudomonas therapy with oral ciprofloxacin (15 mg/kg twice daily; maximum dosage 750 mg twice daily) or intravenous ceftazidime plus tobramycin (CAZ/TM) for 14 days. Clinical improvement was observed in 93% of patients treated with oral ciprofloxacin and in 96% of those receiving parenteral therapy. Transient suppression of Pseudomonas aeruginosa was achieved in 63% of patients at the end of the course of iv CAZ/TM therapy and in 24% receiving ciprofloxacin. Ultrasound examination and nuclear magnetic resonance imaging scans showed no evidence of cartilage toxicity in any of the ciprofloxacin-treated patients. Musculoskeletal adverse events were reported with similar frequency in the two groups of patients (7% in the group receiving ciprofloxacin therapy and 11% in the IV CAZ/TM group). The only sustained musculoskeletal symptom was a case of synovitis in a patient receiving parenteral CAZ/TM. Ciprofloxacin thus appears to...Continue Reading

References

Jun 1, 1979·Toxicology·P K Gupta, R C Gupta
Mar 1, 1990·Diagnostic Microbiology and Infectious Disease·T T Rubio
Oct 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·U B SchaadR Kraemer
Jan 1, 1988·Reviews of Infectious Diseases·W ChristB Ulbrich
May 1, 1986·The Journal of Pediatrics·A L Smith
Nov 1, 1982·Pediatric Infectious Disease·B Boxerbaum
Jan 1, 1997·The Pediatric Infectious Disease Journal·U B SchaadB Hampel
Jan 1, 1974·Pediatric Radiology·A R Chrispin, A P Norman

❮ Previous
Next ❯

Citations

Sep 5, 2003·The Lancet Infectious Diseases·Dominique GendrelJosette Raymond
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Brady S MoffettPeter J Mogayzel
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellPatrice Courvalin
Sep 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gale R BursteinJohn S Moran
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E BurkhardtU B Schaad
Mar 17, 2010·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Van P NgoLaurene Mascola
May 20, 2000·The Pediatric Infectious Disease Journal·A JohanssonA Tärnvik
Apr 17, 2001·The Pediatric Infectious Disease Journal·M BaldA M Wingen
Apr 9, 2004·The Pediatric Infectious Disease Journal·Vasiliki Drossou-AgakidouGeorgios Kremenopoulos
Dec 23, 2003·The Pediatric Infectious Disease Journal·Richard Grady
Apr 9, 2009·Journal of Pediatric Orthopedics·Jason M SansoneKenneth J Noonan
Sep 29, 2007·The Pediatric Infectious Disease Journal·Urs B Schaad
Jul 26, 2011·Archives of Disease in Childhood·Abiodun AdefurinImti Choonara
Aug 30, 2008·American Journal of Respiratory and Critical Care Medicine·Milene T SaavedraJerry A Nick
Sep 5, 2009·American Journal of Respiratory and Critical Care Medicine·Patrick A FlumeUNKNOWN Clinical Practice Guidelines for Pulmonary Therapies Committee
Jun 8, 2001·Paediatric Drugs·D Gendrel, F Moulin
May 6, 2005·Paediatric Drugs·Shamez Ladhani, Mehdi Garbash
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Nov 25, 2006·European Journal of Clinical Pharmacology·Federico MarchettiMaurizio Bonati
Feb 24, 2006·The Journal of Pediatrics·Thomas FerkolCarlos E Milla
Sep 20, 2002·The Journal of Toxicological Sciences·Akio NagaiYasuhito Kawamura
Jul 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F B SpenckerA C Rodloff
Mar 3, 2015·International Journal of Antimicrobial Agents·Nicola Principi, Susanna Esposito
Feb 13, 2016·Journal of Clinical Pharmacology·Karisma Patel, Jennifer L Goldman
Aug 5, 2000·The Annals of Pharmacotherapy·A A Alghasham, M C Nahata
Oct 27, 2015·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Leah Molloy, Kristen Nichols
Aug 17, 2005·Infectious Disease Clinics of North America·Urs B Schaad
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Matthew N HurleyPatrick Flume
Jul 15, 2016·The Cochrane Database of Systematic Reviews·Tracey RemmingtonChristian Harkensee
Nov 2, 2014·Expert Review of Hematology·Thomas Lehrnbecher, Lillian Sung
Jul 19, 2016·Clinical Medicine Insights. Pediatrics·Corinne A MuirheadKelvin D MacDonald
May 21, 2011·The Clinical Respiratory Journal·Elissa Charlotte BriggsKelvin David MacDonald
Jul 1, 2001·Paediatrics & Child Health·J Langley
Jan 1, 2008·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Sharon M ErdmanJanet F Hindler
Aug 18, 2021·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Georges AzarGeorges Caputo
Jun 5, 2003·Pediatrics·Martin ChalumeauUNKNOWN Pediatric Fluoroquinolone Safety Study Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.